# Combination antiretroviral therapy: Science

Source page: https://www.materialinsights.org/technologies/antiretroviral_therapy/tech-science/

#### Principles

The science it rests on, with why each principle matters to it
 Relies on

- [DNA replication and polymerase](https://www.materialinsights.org/science/dna_replication/) HIV must copy its RNA into DNA with reverse transcriptase; the first drug, AZT, is a nucleoside reverse transcriptase inhibitor that blocks this copying ^[1].
- [The genetic code](https://www.materialinsights.org/science/genetic_code/) Knowing the virus's genes and the proteins they code for let researchers pick enzyme targets such as protease and integrase ^[1].
 Limited by

- [Evolution by natural selection](https://www.materialinsights.org/science/evolution_natural_selection/) Drug-resistant variants of HIV can evolve rapidly while the virus keeps copying, which is why drugs from different classes are combined ^[1].

as of 2026-11-11

#### Discoveries

The discoveries that made it possible: when, by whom and what was found

| Year | Who | What |
|---|---|---|
| 1983 | Françoise Barré-Sinoussi, Luc Montagnier and the Institut Pasteur team | First description of the virus later named HIV ^[3] |
| 1995 | ACTG 175 trial investigators | Two-drug combinations shown to work better than AZT alone ^[1] |
| 1996 | HIV researchers | Triple-drug therapy shown to suppress HIV replication durably ^[1] |

as of 2026-11-11

#### The science explained

The science behind it explained for a curious reader

Think of HIV as a burglar who must get through three locked doors in turn to take over a cell: one to copy its genes into DNA, one to hide that DNA in the cell's genome, and one to finish new virus particles. Each drug class jams one lock ^[1]. The burglar is a quick and sloppy copier, so among millions of copies some can pick any single jammed lock. Jam two or three locks at once and a copy would need to pick them all in one go, which almost never happens. This is why one drug alone, as with AZT in 1987, worked only for a while, and why three-drug treatment from 1996 could hold the virus down for years ^[1].

as of 2026-11-11

#### Sources

1. [Antiretroviral Drug Discovery and Development](https://www.niaid.nih.gov/diseases-conditions/antiretroviral-drug-development) National Institute of Allergy and Infectious Diseases (NIH)
2. [Nobel Prize in Medicine 2008 awarded to Professors Françoise Barré-Sinoussi and Luc Montagnier](https://www.pasteur.fr/en/whats-new/press-area/press-releases-and-press-kits/nobel-prize-medicine-2008-awarded-professors-francoise-barre-sinoussi-and-luc-montagnier) Institut Pasteur, 2008

## Other sections

- [Summary](https://www.materialinsights.org/technologies/antiretroviral_therapy/index.md)
- [Overview](https://www.materialinsights.org/technologies/antiretroviral_therapy/tech-overview/index.md)
- [Evolution](https://www.materialinsights.org/technologies/antiretroviral_therapy/tech-evolution/index.md)
- [Materials](https://www.materialinsights.org/technologies/antiretroviral_therapy/tech-materials/index.md)
- [Energy footprint](https://www.materialinsights.org/technologies/antiretroviral_therapy/tech-energy-footprint/index.md)
- [Industries](https://www.materialinsights.org/technologies/antiretroviral_therapy/tech-industries/index.md)
